Jeffrey S. Ross, MD

Articles by Jeffrey S. Ross, MD

42 Tissue and Liquid Biopsy–Based Comprehensive Genomic Profiling Reveal Mechanisms of Therapy Resistance and Rare Targetable Alterations in Breast Cancer

ByEthan Sokol,Smruthy Sivakumar,Dexter X. Jin,Hanna Tukachinsky,Karthikeyan Murugesan,Dean Pavlick,Jeffrey S. Ross, MD,Garrett M. Frampton,Geoffrey R. Oxnard, MD,Priti S. Hegde

April 18th 2022

DNA Ploidy and Cell Cycle Analysis in Cancer Diagnosis and Prognosis

ByJeffrey S. Ross, MD

June 1st 1996

This review focuses on the clinical utility and potential value of cell cycle analysis and DNA ploidy interpretation in the diagnosis of human tumors, the application of these techniques to cytologic diagnosis, and their capability

Latest Updated Articles

DNA Ploidy and Cell Cycle Analysis in Cancer Diagnosis and Prognosis
June 1st 1996

Jeffrey S. Ross, MD

Articles by Jeffrey S. Ross, MD

42 Tissue and Liquid Biopsy–Based Comprehensive Genomic Profiling Reveal Mechanisms of Therapy Resistance and Rare Targetable Alterations in Breast Cancer

DNA Ploidy and Cell Cycle Analysis in Cancer Diagnosis and Prognosis

Latest Updated Articles

Trending on CancerNetwork

The Case for Frontline Zongertinib in HER2-Mutant NSCLC

Isatuximab-Based Therapy Shows “Impressive” PFS Projections in NDMM

Durvalumab Plus Enfortumab Vedotin Earns FDA Priority Review in MIBC

Emerging Endocrine Doublets and Serial ESR1 Testing in HR+/HER2− mBC

Subcutaneous Isatuximab Enhances Patient Experience in Multiple Myeloma